Noxopharm Limited (ASX:NOX) has disclosed a proposed issue of 1,240,351 fully paid ordinary shares to non-executive directors in lieu of fees, following shareholder approval obtained at the company's 2026 Annual General Meeting held on 17 November 2026.
Key Points
- 1,240,351 fully paid ordinary shares to be issued to non-executive directors in lieu of directors' fees
- Shares valued at a deemed issue price of $0.0907 per share, calculated using the company's 10-day VWAP up to and including 30 June 2026
- Total fees to be converted amount to $112,500, owed to directors as at 30 June 2026
- Shareholder approval for the issue was obtained at the 2026 AGM held on 17 November 2026
- Proposed issue date is 19 November 2026
Shareholder Approval at 2026 AGM
According to the filing, Noxopharm Limited sought and obtained shareholder approval for the share issue at its 2026 Annual General Meeting, held on 17 November 2026. The approval covered the issue of shares to non-executive directors in lieu of fees. The filing confirms the approval condition was met on the actual determination date of 17 November 2026, with security holder approval secured under ASX Listing Rule 7.1. No additional placement capacity under Listing Rules 7.1 or 7.1A was used for this issue.
Terms of the Director Fee Share Issue
The filing states that as at 30 June 2026, Noxopharm's directors were owed a total of $112,500 in fees. These fees are to be converted into fully paid ordinary shares at a deemed issue price of $0.0907 per share. The number of shares to be issued to each director was calculated based on the company's 10-day volume-weighted average price of shares traded on ASX up to and including 30 June 2026. The filing discloses that no cash consideration will be received by the company for the issue of these securities.
Issue Timetable and Security Details
The proposed issue date for the 1,240,351 fully paid ordinary shares is 19 November 2026, the same date as the filing. The securities form part of an existing class of quoted ordinary fully paid shares on the ASX under the code NOX. According to the filing, the securities will rank equally in all respects from their issue date with the existing issued securities in that class. The filing confirms no lead manager, broker or underwriter is involved in the proposed issue, and no material fees or costs are expected to be incurred by the company in connection with it.




Please wait processing your request...